2. Eisai's Policy Positions
May 7, 2012
Eisai has corporate policies on various public policy issues:
- Access to medicines
- Intellectual property
- Improving access through affordable pricing
- Quality of medicines
- Pharmacovigilance
- Clinical trial registration and result disclosure
Eisai also supports IFPMA policies on global health issues, some of which are listed below: